Home›Stock Screener›Advanced Enzyme Tech›Quarterly Results

Advanced Enzyme Tech Quarterly Results

Latest Quarter Net Profit
₹45 Cr
QMar 2026
Quarterly Results

Advanced Enzyme Tech quarterly results. In Mar 2026, Advanced Enzyme Tech (ADVENZYMES) reported revenue ₹211 Cr and net profit ₹45 Cr — revenue +19.9% YoY. Review ADVENZYMES price earnings ratio to evaluate earnings-based valuation against sector peers.

ADVENZYMES Quarterly Results — Revenue, Profit & EPS Highlights

Advanced Enzyme Tech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Advanced Enzyme Tech share price chart.

  • Revenue of ₹211 Cr in Mar 2026 (+3.9% vs Jun 2026, +19.9% vs Mar 2025)
  • Net Profit of ₹45 Cr in Mar 2026 (+15.4% vs Jun 2026, +66.7% vs Mar 2025)
  • EBITDA of ₹71 Cr in Mar 2026 (+10.9% vs Jun 2026)
  • Operating Margin of 31.0% in Mar 2026 (+4.0pp vs Jun 2026)
  • Earnings Per Share of ₹3.84 in Mar 2026 (+16.0% vs Jun 2026)

Advanced Enzyme Tech Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ADVENZYMES quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 211 203 195 176 195 3.9% 19.9%
Net Profit (₹ Cr) 45 39 45 27 40 - -
EBITDA (₹ Cr) 71 64 70 54 65 - -
EPS (₹) 3.84 3.31 3.87 2.37 3.57 - -
Operating Margin (%) 31.0% 27.0% 33.0% 27.0% 30.0% - -

ADVENZYMES Share Price Trend — 1-Year Movement Across Quarterly Results

Advanced Enzyme Tech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check ADVENZYMES market cap trends to track the company's total market size over time.

Profitability Ratios

Profit Margin 21.3%
EBITDA Margin 33.6%
Operating Margin 31.0%
ROE (Annual) 10.7%

Balance Sheet Highlights

Total Assets ₹1,839 Cr
Total Equity ₹1,683 Cr
Current Assets ₹1,044 Cr
Current Liabilities ₹49 Cr

Cash Flow Analysis

Operating Cash Flow ₹157 Cr
Investing Cash Flow ₹-72 Cr
Financing Cash Flow ₹-70 Cr
Net Cash Flow ₹15 Cr

Current Market Data

Current Price ₹272.40
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 176
Sept 2025 195
Jun 2026 203
Mar 2026 211

Net Profit Trend (₹ Cr)

Mar 2025 27
Sept 2025 45
Jun 2026 39
Mar 2026 45

Operating Margin Trend (%)

Mar 2025 27.0%
Sept 2025 33.0%
Jun 2026 27.0%
Mar 2026 31.0%

ADVENZYMES vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Advanced Enzyme Tech latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹253,522.49 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores